CJ-30060

· HK inno.N Corporation

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CJ-30060, covering 2017-01-04 to 2018-05-30. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Safety and Efficacy of CJ-30060 in Hypertensive Patients With Hyperlipidemia [Phase 3]